# OCEA (Ocean Biomedical, Inc.) - SEC EDGAR Financial Statements

> Ocean Biomedical, Inc. reported $1.58M in total assets and a net loss of $30.72M through December 31, 2024 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OCEA
- Markdown: https://convexityos.com/fundamentals/OCEA.md
- SEC CIK: 0001869974
- Reporting currency: USD
- Latest filing period: March 31, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001869974&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | -- | Dec 31, 2024 |
| Operating Income | FY 2024 | -$4.16M | Operating profit |
| Net Income | FY 2024 | -$30.72M | GAAP bottom line |
| Diluted EPS | FY 2024 | -$0.34 | Split-adjusted |
| Free Cash Flow | FY 2024 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2025 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| Research & Development | $26K | $709K | $8.41M |
| Total Operating Expenses | $3.80M | $10.21M | $16.12M |
| **Operating Income** | -$3.80M | -$10.21M | -$16.12M |
| Interest Income | -- | -- | $1.52M |
| Interest Expense | -- | $50K | $691 |
| **Net Income** | -$9.48M | -$114.5M | -$17.36M |
| Basic EPS | -$0.34 | -$4.35 | -$0.74 |
| **Diluted EPS** | -$0.34 | -$4.35 | -$0.74 |
| Basic Shares Outstanding | 27.5M | 26.3M | 23.4M |
| Diluted Shares Outstanding | 27.5M | 26.3M | 23.4M |

### Income Statement (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $18K | $0 | $0 | $0 | $26K | -$17K | $305K | $28K |
| Total Operating Expenses | $958K | $1.75M | $768K | $682K | $595K | -$660K | $2.65M | $2.83M |
| **Operating Income** | -$958K | -$1.75M | -$768K | -$682K | -$595K | $660K | -$2.65M | -$2.83M |
| Interest Expense | $343K | -- | -- | -- | $637K | $13K | $0 | $24K |
| **Net Income** | -$8.24M | -$1.54M | -$3.70M | -$17.23M | $13.00M | -$16.86M | -$14.09M | -$11.43M |
| Basic EPS | -$0.09 | -- | -$0.13 | -$0.63 | $0.48 | -- | -$0.53 | -$0.43 |
| **Diluted EPS** | -$0.09 | -- | -$0.13 | -$0.63 | $0.48 | -- | -$0.53 | -$0.43 |
| Basic Shares Outstanding | 91.0M | -- | 27.5M | 27.5M | 27.3M | -- | 26.6M | 26.5M |
| Diluted Shares Outstanding | 91.0M | -- | 27.5M | 27.5M | 27.3M | -- | 26.6M | 26.5M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $4.0K | $34K | $0 |
| **Cash & Short-Term Investments** | -- | $4.0K | $34K | $0 |
| **Total Current Assets** | $812K | $2.11M | $1.84M | $1.55M |
| **Total Non-Current Assets** | $90K | $3.39M | $0 | $107.1M |
| **Total Assets** | $902K | $5.50M | $1.84M | $108.7M |
| Accounts Payable | $15.90M | $16.18M | $11.44M | $34K |
| Short-Term Debt | -- | $3.20M | -- | -- |
| **Total Current Liabilities** | $33.89M | $30.01M | $12.66M | $246K |
| **Total Non-Current Liabilities** | $64.63M | $66.25M | $0 | $3.15M |
| **Total Liabilities** | $98.52M | $96.26M | $12.66M | $3.40M |
| **Total Debt (incl. Leases)** | -- | $3.20M | -- | -- |
| Retained Earnings | -$205.5M | -$196.1M | -$81.59M | -$564K |
| **Total Stockholders' Equity** | -$97.62M | -$90.76M | -$10.82M | -$6.66M |
| Total Equity | -$97.62M | -$90.76M | -$10.82M | -$6.66M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $4.0K | $19K | $4.0K | $31K | -- |
| **Cash & Short-Term Investments** | -- | -- | -- | $4.0K | $19K | $4.0K | $31K | -- |
| **Total Current Assets** | $1.49M | $812K | $1.04M | $1.28M | $1.80M | $2.11M | $1.03M | $2.16M |
| **Total Non-Current Assets** | $90K | $90K | $90K | $574K | $1.15M | $3.39M | $0 | $18.76M |
| **Total Assets** | $1.58M | $902K | $1.13M | $1.85M | $2.95M | $5.50M | $1.03M | $20.92M |
| Accounts Payable | $16.39M | $15.90M | $16.57M | $17.18M | $16.88M | $16.18M | $16.05M | $14.04M |
| Short-Term Debt | -- | -- | -- | -- | -- | $3.20M | -- | -- |
| **Total Current Liabilities** | $26.57M | $33.89M | $31.82M | $30.74M | $30.11M | $30.01M | $30.85M | $26.68M |
| **Total Non-Current Liabilities** | $67.41M | $64.63M | $65.57M | $63.86M | $48.62M | $66.25M | $45.40M | $2.64M |
| **Total Liabilities** | $93.98M | $98.52M | $97.39M | $94.59M | $78.73M | $96.26M | $76.25M | $29.32M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $3.20M | -- | -- |
| Retained Earnings | -$213.8M | -$205.5M | -$204.0M | -$200.3M | -$183.1M | -$196.1M | -$179.2M | -$162.0M |
| **Total Stockholders' Equity** | -$92.40M | -$97.62M | -$96.26M | -$92.74M | -$75.78M | -$90.76M | -$75.22M | -$61.66M |
| Total Equity | -$92.40M | -$97.62M | -$96.26M | -$92.74M | -$75.78M | -$90.76M | -$75.22M | -$61.66M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| Net Income | -$9.48M | -$114.5M | -$17.36M |
| Stock-Based Compensation | $745K | $1.21M | $12.38M |
| Change in Payables | -- | -- | $290K |
| **Operating Cash Flow** | -$4.18M | -$9.43M | -$993K |
| Purchases of Investments | -- | -- | -$2.10M |
| **Investing Cash Flow** | -- | -- | -$2.10M |
| Common Stock Issued | -- | $14.26M | -- |
| **Financing Cash Flow** | $3.40M | $10.40M | $967K |
| **Net Change in Cash** | -$780K | $970K | -$26K |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.24M | -$1.54M | -$3.70M | -$17.23M | $13.00M | -$16.86M | -$14.09M | -$11.43M |
| Stock-Based Compensation | $186K | $186K | $186K | $187K | $186K | $187K | $186K | $186K |
| **Operating Cash Flow** | -$356K | -$2.45M | -$957K | -$290K | -$485K | -$866K | -$1.13M | -$4.78M |
| Common Stock Issued | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Financing Cash Flow** | $909K | -- | -- | -- | -- | $839K | $0 | $6.64M |
| **Net Change in Cash** | $553K | -$16K | $11K | -$290K | -$485K | -$27K | -$1.13M | $1.85M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| Return on Assets (ROA) | -1051.0% | -2080.8% | -942.4% |
| Current Ratio | 0.02x | 0.07x | 0.15x |
| Quick Ratio | -- | 0.00x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -1941.8% | -1051.0% | -2190.4% | -1900.5% | -997.1% | -2080.8% | -9562.9% | -421.5% |
| Current Ratio | 0.06x | 0.02x | 0.03x | 0.04x | 0.06x | 0.07x | 0.03x | 0.08x |
| Quick Ratio | -- | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | -- |
| Operating Income Growth (YoY) | -- | -365.6% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -163.4% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -118.8% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
